Devin W. Steenkamp, MBChB
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Endocrinology, Diabetes, Nutrition & Weight Management

MBChB, University of Pretoria



Devin Steenkamp is Associate Professor of Medicine in the Section of Endocrinology, Diabetes, Nutrition and Weight Management at Chobanian and Avedisian School of Medicine, Boston, MA. Dr. Steenkamp is an adult endocrinologist with a particular interest in type 1 diabetes, atypical diabetes phenotypes and diabetes technology. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine. He established the diabetes technology program, with a particular focus on utilizing modern technologies to improve the care and outcomes for underserved adults living with diabetes.

In his clinical leadership role, he is responsible for leading a team of multidisciplinary clinicians with specific expertise in implementing advanced diabetes technologies into care and has overseen the development of various innovative clinical programs. Dr. Steenkamp has also been a leader integral to the advancement of the diabetes clinical research program and has been an investigator on multiple multi-center clinical trials and translational projects, sponsored by the NIH, various foundations and industry sponsors.

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research





Sandlot 1: Insights Engine Training Set for the Determination of Problem Areas in Diabetes ADC-US-EXP-23246
12/01/2024 - 11/30/2028 (PI)
Abbott Laboratories

Continuous glucose monitoring in a community study: determinants and prediction of diabetes mellitus development in the Framinghm Heart Study.
04/01/2022 - 03/31/2027 (Subcontract PI)
PI: Devin W. Steenkamp, MBChB
Trustees of Boston University, BUMC NIH NIDDK
1R01DK129305-01

INHALE-3 A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Afrezza Combined with Degludec (Tresiba) Versus Usual Care in Adults with Type 1 Diabetes
06/21/2023 - 06/20/2026 (PI)
JAEB Center For Health Research, Inc.


TP-0013437 A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)
06/01/2023 - 05/31/2026 (PI)
JAEB Center For Health Research, Inc.


FOCUS - Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes
07/01/2019 - 07/31/2025 (PI)
Novo Nordisk


Quality Improvement (Q1) Program
04/28/2021 - 06/30/2025 (PI)
T1D Exchange, Inc.


ADC-US-RES-19185: Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People with T2 Diabetes
05/11/2022 - 05/10/2025 (PI)
Abbott Laboratories


REDUCING INEQUITIES IN DIABETES TECHNOLOGY
02/01/2023 - 03/31/2024 (PI)
T1D Exchange, Inc.


F3Z-MC-IORN Meal-centric Insulin Dosing for Optimized Post-Prandial Glucose Control in People Using Multiple Daily Injections
06/04/2021 - 05/01/2023 (PI)
Lilly USA, LLC


Glycemla Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
08/01/2014 - 01/28/2023 (PI)
Mass General Hosp NIH-NIDDK

Showing 10 of 17 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Levy CJ, Kanapka L, Brown SA, Marks S, Spaic T, Steenkamp DW, Lu VS, Zhao P, Lum JW, Beck RW, Pinsker JE. Simplified Meal Bolus Strategies with Control-IQ+ Automated Insulin Delivery Are Safe and Effective in Adults with Type 2 Diabetes. Diabetes Technol Ther. 2025 Nov 14. PMID: 41264341; DOI: 10.1177/15209156251395035;
     
  2. Kudva YC, Raghinaru D, Lum JW, Graham TE, Liljenquist D, Spanakis EK, Pasquel FJ, Ahmann A, Ahn DT, Aleppo G, Blevins T, Kruger D, Brown SA, Levy CJ, Weinstock RS, Steenkamp DW, Spaic T, Hirsch IB, Broyles F, Rickels MR, Tsoukas MA, Raskin P, Hatipoglu B, Desjardins D, Terry AN, Singh LG, Davis GM, Schmid C, Kravarusic J, Coyne K, Casaubon L, Espinosa V, Jones JK, Estrada K, Afreen S, Levister C, O'Malley G, Liu SL, Marks S, Peleckis AJ, Pasqua MR, Tardio V, Kurek C, Luker RD, Churchill J, Tajrishi FZ, Dean A, Dennis B, Fronczyk E, Perez J, Mukhashen S, Dhillon J, Ipek A, Bzdick S, Castillo AA, Driscoll M, Averkiou X, Dalton-Bakes CV, Moore A, Jordan LF, Lesniak A, Pinsker JE, Sasson-Katchalski R, Campos T, Spanbauer C, Kanapka L, Kollman C, Beck RW. A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes. Obstet Gynecol Surv. 2025 Nov 01; 80(11):681-683. PMID: 41194356; DOI: 10.1097/OGX.0000000000001463;
     
  3. Siskind SM, Dymek R, Fantasia KL, O'Brien K, Steenkamp DW. Continuous Glucose Monitoring-Enhanced eConsult Improves Clinical Outcomes in Adults Living With Diabetes in a Safety Net Primary Care Setting. J Diabetes Res. 2025; 2025:5547910.View Related Profiles. PMID: 40799672; PMCID: PMC12343161; DOI: 10.1155/jdr/5547910;
     
  4. Bakhshi B, Sultana N, Lin H, Fei D, Vallejo V, Gatanti A, Steenkamp DW, Murabito JM, McKeown NM, Walker ME, Spartano NL. Associations of diet composition and quality with continuous glucose monitor-derived glycemic metrics in a community-based cohort. Am J Clin Nutr. 2025 Oct; 122(4):942-953.View Related Profiles. PMID: 40749968; PMCID: PMC12495531; DOI: 10.1016/j.ajcnut.2025.07.026;
     
  5. Kang JW, Arnold MA, Steenkamp D, Tapsak MA, Mäntele W, Khang Y, Jue M, So PTC. Workshop on Noninvasive Glucose Monitoring 2024. J Diabetes Sci Technol. 2025 Jul; 19(4):1144-1149. PMID: 40152467; PMCID: PMC11955980; DOI: 10.1177/19322968251329371;
     
  6. Kelly J, Steenkamp D, Brouillard E, Wolpert H. Weight gain as a complication of intensification of glucose control with automated insulin delivery systems. Diabet Med. 2025 Aug; 42(8):e70031.View Related Profiles. PMID: 40126180; DOI: 10.1111/dme.70031;
     
  7. Kudva YC, Raghinaru D, Lum JW, Graham TE, Liljenquist D, Spanakis EK, Pasquel FJ, Ahmann A, Ahn DT, Aleppo G, Blevins T, Kruger D, Brown SA, Levy CJ, Weinstock RS, Steenkamp DW, Spaic T, Hirsch IB, Broyles F, Rickels MR, Tsoukas MA, Raskin P, Hatipoglu B, Desjardins D, Terry AN, Singh LG, Davis GM, Schmid C, Kravarusic J, Coyne K, Casaubon L, Espinosa V, Jones JK, Estrada K, Afreen S, Levister C, O'Malley G, Liu SL, Marks S, Peleckis AJ, Pasqua MR, Tardio V, Kurek C, Luker RD, Churchill J, Tajrishi FZ, Dean A, Dennis B, Fronczyk E, Perez J, Mukhashen S, Dhillon J, Ipek A, Bzdick S, Atakov Castillo A, Driscoll M, Averkiou X, Dalton-Bakes CV, Moore A, Jordan LF, Lesniak A, Pinsker JE, Sasson-Katchalski R, Campos T, Spanbauer C, Kanapka L, Kollman C, Beck RW. A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes. N Engl J Med. 2025 May 08; 392(18):1801-1812. PMID: 40105270; DOI: 10.1056/NEJMoa2415948;
     
  8. Spartano NL, Sultana N, Lin H, Cheng H, Lu S, Fei D, Murabito JM, Walker ME, Wolpert HA, Steenkamp DW. Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes. J Clin Endocrinol Metab. 2025 Mar 17; 110(4):1128-1134.View Related Profiles. PMID: 39257191; PMCID: PMC11913108; DOI: 10.1210/clinem/dgae626;
     
  9. Alexanian SM, Cheney MC, Bello Ramos JC, Spartano NL, Wolpert HA, Steenkamp DW. Impact of Meal Insulin Bolus Timing and Bedtime Snacking on Continuous Glucose Monitoring-Derived Glycemic Metrics in Hospitalized Inpatients. Diabetes Technol Ther. 2025 Jul; 27(7):511-516.View Related Profiles. PMID: 40067436
     
  10. Hirsch IB, Beck RW, Marak MC, Kudva Y, Akturk HK, Bhargava A, Codorniz K, Diner J, Aleppo G, Blevins T, Levy CJ, Raskin P, Castorino K, Manessis A, Pickering D, Steenkamp DW, Weinstock RS, Bode BW, Hamdy O, Nguyen QT, Kipnes M, Ruedy KJ, Desjardins D, Haider Z, Jacobson C, Lee S, Buse JB, Klein KR, O'Malley G, Church MM, Mottalib A, Baran JD, Kurek C, Rizvi S, Donahue C, Tamarez D, Atakov Castillo A, Borgman S, Frey S, Calhoun P. A Randomized Trial Comparing Inhaled Insulin Plus Basal Insulin Versus Usual Care in Adults With Type 1 Diabetes. Diabetes Care. 2025 Mar 01; 48(3):353-360. PMID: 39641970; PMCID: PMC11870290; DOI: 10.2337/dc24-1832;
     
Showing 10 of 66 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 66 publications over 14 distinct years, with a maximum of 12 publications in 2025

YearPublications
20111
20134
20145
20152
20164
20179
20182
20196
20202
20215
20226
20233
20245
202512


2021 Boston Medical Center: Lewis E. Braverman Endocrinology Teaching Award
2018 Department of Medicine, BUCASM: Robert Dawson Evans Junior Faculty Mentoring Award
2016 Kroc Institute: Kroc Diabetes Award
2009-2011 St Luke’s-Roosevelt Hospital Center, Columbia University, NY: Outstanding Resident Award
2003 University of Pretoria School of Medicine: Distinction in; Orthopedics, Surgery, Family Medicine, Pediatrics, Community Obstetrics and Urology
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Type 1 Diabetes Mellitus
Proinsulin C Peptide
MODY

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
Contact for Mentoring:

75 E. Newton St
Boston MA 02118
Google Map

Download vCard

Steenkamp's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (184) concept(s)
_
Co-Authors
See all (45) people
_
Similar People
See all (60) people
_
Same Department
Search Department